Researchers Karijn Suijkerbuijk

Karijn Suijkerbuijk

Full Professor

Strategic program(s):

Biography

Karijn Suijkerbuijk is a translational medical oncologist with special interest in melanoma and immunotherapy. During her PhD, she performed research on tumor epigenetics in breast cancer in the lab of Professor Saraswati Sukumar at the Sidney Kimmel Cancer Center at Johns Hopkins University. Dr. Suijkerbuijk currently participates in multiple phase II and III clinical trials on immune checkpoint inhibitors. She published papers in Oncogene, Annals of Oncology and JNCI, received research grants from KWF and NWO and was awarded an ASCO Merit Award. Her current research focuses on clinical and immunological parameters assoaciated with immune related adverse events during checkpoint inhibition and clinicopathological factors associated with checkpoint inhibitor response.

Strategic program(s):

Contact

ksuijke2@umcutrecht.nl

Pure profile

Research groups

Molecular and cellular host-microbiota interactions

Research aim

Our research aims to unravel how the products from pathogenic and beneficial bacterial species within the intestinal microbiota contribute to human health and disease.

Go to group

Recent publications

All publications

Adverse Events in Anti-PD-1-Treated Adjuvant and First-Line Advanced Melanoma Patients Daan Jan Willem Rauwerdink, Olivier van Not, Melissa de Meza, Remco van Doorn, Jos van der Hage, A J M van den Eertwegh, John B Haanen, Maureen J B Aarts, Franchette W P J van den Berkmortel, Christiaan U Blank, Marye J Boers-Sonderen, Jan Willem B de Groot, Geke A P Hospers, Djura Piersma, Rozemarijn S van Rijn, A M Stevense-den Boer, Astrid A M van der Veldt, Gerard Vreugdenhil, Michel W J M Wouters, Karijn P M Suijkerbuijk, Ellen Kapiteijn
Cancers, 2024, vol. 16

Adjuvant treatment with anti-PD-1 in acral melanoma Manja Bloem, Olivier J. van Not, Maureen J.B. Aarts, Franchette W.P.J. van den Berkmortel, Christian U. Blank, Willeke A.M. Blokx, Marye J. Boers-Sonderen, Johannes J. Bonenkamp, Jan Willem B. de Groot, John B. Haanen, Geke A.P. Hospers, Ellen W. Kapiteijn, Melissa M. de Meza, Djura Piersma, Rozemarijn S. van Rijn, Marion A.M. Stevense-den Boer, Astrid A.M. van der Veldt, Gerard Vreugdenhil, Alfons J.M. van den Eertwegh, Karijn P.M. Suijkerbuijk, Michel W.J.M. Wouters
International Journal of Cancer, 2024, vol. 155, p.1455-1465

Improving survival in advanced melanoma patients Olivier J van Not, Alfons J M van den Eertwegh, John B Haanen, Christian U Blank, Maureen J B Aarts, Jesper van Breeschoten, Franchette W P J van den Berkmortel, Jan-Willem B de Groot, Geke A P Hospers, Rawa K Ismail, Ellen Kapiteijn, Manja Bloem, Melissa M De Meza, Djura Piersma, Rozemarijn S van Rijn, Marion A M Stevense-den Boer, Astrid A M van der Veldt, Gerard Vreugdenhil, Marye J Boers-Sonderen, Willeke A M Blokx, Michel W J M Wouters, Karijn P M Suijkerbuijk
EClinicalMedicine, 2024, vol. 69, p.1-10

Long-Term Survival in Patients With Advanced Melanoma Olivier J van Not, Alfons J M van den Eertwegh, University Groningen, Manja Bloem, John B Haanen, Rozemarijn S van Rijn, Maureen J B Aarts, Franchette W P J van den Berkmortel, Christian U Blank, Marye J Boers-Sonderen, Jan Willem de Groot J W B, Geke A P Hospers, Ellen Kapiteijn, Brenda Leeneman, Piersma D, Marion Stevense-den Boer, Astrid A M van der Veldt, Gerard Vreugdenhil G, Michel W J M Wouters, Willeke A M Blokx, Karijn P M Suijkerbuijk
JAMA network open, 2024, vol. 7

Multi-omic analysis identifies hypoalbuminemia as independent biomarker of poor outcome upon PD-1 blockade in metastatic melanoma Lindsay V M Leek, Jessica C L Notohardjo, Karlijn de Joode, Eline L Velker, John B A G Haanen, Karijn P M Suijkerbuijk, Maureen J B Aarts, Jan Willem B de Groot, Ellen Kapiteijn, Franchette W P J van den Berkmortel, Hans M Westgeest, Tanja D de Gruijl, Valesca P Retel, Edwin Cuppen, Astrid A M van der Veldt, Mariette Labots, Emile E Voest, Joris van de Haar, Alfons J M van den Eertwegh
Scientific Reports, 2024, vol. 14

BRAF/MEK inhibitor rechallenge in advanced melanoma patients Olivier J Van Not, Alfons J M van den Eertwegh, John B Haanen, Rozemarijn S van Rijn, Maureen J B Aarts, Franchette W P J van den Berkmortel, Christian U Blank, Marye J Boers-Sonderen, Jan Willem W B de Groot, Geke AP Hospers, Ellen Kapiteijn, Manja Bloem, Djura Piersma, Marion Stevense-den Boer, Rik J Verheijden, Astrid A M van der Veldt, Michel W J M Wouters, Willeke A M Blokx, Karijn P M Suijkerbuijk
Cancer, 2024, vol. 130, p.1673-1683

External positions

Chair Dutch Melanoma Treatment Registry